What Are the Benefit of Expanding Access to Weight-Losing Drugs?
Key Insights: Potential Life-Saving Impact: Expanding access to new weight-loss medications could save over 40,000 lives annually in the U.S. Obesity Crisis: 74% of Americans are overweight, and 43% are obese, contributing to severe health issues like type 2 diabetes and cardiovascular disease. Pharmaceutical Breakthrough: GLP-1 receptor agonists (e.g., Ozempic, Wegovy) and GIP/GLP-1 receptor agonists